BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 27386852)

  • 1. Nonrecurrent PMP22-RAI1 contiguous gene deletions arise from replication-based mechanisms and result in Smith-Magenis syndrome with evident peripheral neuropathy.
    Yuan B; Neira J; Gu S; Harel T; Liu P; Briceño I; Elsea SH; Gómez A; Potocki L; Lupski JR
    Hum Genet; 2016 Oct; 135(10):1161-74. PubMed ID: 27386852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonrecurrent 17p11.2p12 Rearrangement Events that Result in Two Concomitant Genomic Disorders: The PMP22-RAI1 Contiguous Gene Duplication Syndrome.
    Yuan B; Harel T; Gu S; Liu P; Burglen L; Chantot-Bastaraud S; Gelowani V; Beck CR; Carvalho CM; Cheung SW; Coe A; Malan V; Munnich A; Magoulas PL; Potocki L; Lupski JR
    Am J Hum Genet; 2015 Nov; 97(5):691-707. PubMed ID: 26544804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: rare CNVs as a cause for missing heritability.
    Zhang F; Seeman P; Liu P; Weterman MA; Gonzaga-Jauregui C; Towne CF; Batish SD; De Vriendt E; De Jonghe P; Rautenstrauss B; Krause KH; Khajavi M; Posadka J; Vandenberghe A; Palau F; Van Maldergem L; Baas F; Timmerman V; Lupski JR
    Am J Hum Genet; 2010 Jun; 86(6):892-903. PubMed ID: 20493460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of classical 17p11.2 deletions, an atypical deletion and RAI1 alterations in patients with features suggestive of Smith-Magenis syndrome.
    Vieira GH; Rodriguez JD; Carmona-Mora P; Cao L; Gamba BF; Carvalho DR; de Rezende Duarte A; Santos SR; de Souza DH; DuPont BR; Walz K; Moretti-Ferreira D; Srivastava AK
    Eur J Hum Genet; 2012 Feb; 20(2):148-54. PubMed ID: 21897445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of Greek patients with suspected hereditary neuropathy with liability to pressure palsies (HNPP): a 15-year experience.
    Karadima G; Koutsis G; Raftopoulou M; Karletidi KM; Zambelis T; Karandreas N; Panas M
    J Peripher Nerv Syst; 2015 Jun; 20(2):79-85. PubMed ID: 26110377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of the Retinoic Acid Induced 1 gene (RAI1) in patients with suspected Smith-Magenis syndrome without the 17p11.2 deletion.
    Vilboux T; Ciccone C; Blancato JK; Cox GF; Deshpande C; Introne WJ; Gahl WA; Smith AC; Huizing M
    PLoS One; 2011; 6(8):e22861. PubMed ID: 21857958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype correlation in Smith-Magenis syndrome: evidence that multiple genes in 17p11.2 contribute to the clinical spectrum.
    Girirajan S; Vlangos CN; Szomju BB; Edelman E; Trevors CD; Dupuis L; Nezarati M; Bunyan DJ; Elsea SH
    Genet Med; 2006 Jul; 8(7):417-27. PubMed ID: 16845274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal deletion and duplication of 17p11.2-11.2: Korean patients with Smith-Magenis syndrome and Potocki-Lupski syndrome.
    Lee CG; Park SJ; Yun JN; Yim SY; Sohn YB
    J Korean Med Sci; 2012 Dec; 27(12):1586-90. PubMed ID: 23255863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions.
    Girirajan S; Elsas LJ; Devriendt K; Elsea SH
    J Med Genet; 2005 Nov; 42(11):820-8. PubMed ID: 15788730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of uncommon recurrent Potocki-Lupski syndrome-associated duplications and the distribution of rearrangement types and mechanisms in PTLS.
    Zhang F; Potocki L; Sampson JB; Liu P; Sanchez-Valle A; Robbins-Furman P; Navarro AD; Wheeler PG; Spence JE; Brasington CK; Withers MA; Lupski JR
    Am J Hum Genet; 2010 Mar; 86(3):462-70. PubMed ID: 20188345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intellectual and Behavioral Phenotypes of Smith-Magenis Syndrome: Comparisons between Individuals with a 17p11.2 Deletion and Pathogenic
    Linders CC; van Eeghen AM; Zinkstok JR; van den Boogaard MJ; Boot E
    Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdeletion on 17p11.2 in a Smith-Magenis syndrome patient with mental retardation and congenital heart defect: first report from China.
    Huang C; Yang YF; Zhang H; Xie L; Chen JL; Wang J; Tan ZP; Luo H
    Genet Mol Res; 2012 Aug; 11(3):2321-7. PubMed ID: 22911601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed diagnosis in a house of correction: Smith-Magenis syndrome due to a de novo nonsense RAI1 variant.
    Yeetong P; Vilboux T; Ciccone C; Boulier K; Schnur RE; Gahl WA; Huizing M; Laje G; Smith AC
    Am J Med Genet A; 2016 Sep; 170(9):2383-8. PubMed ID: 27311559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smith-Magenis syndrome: haploinsufficiency of RAI1 results in altered gene regulation in neurological and metabolic pathways.
    Elsea SH; Williams SR
    Expert Rev Mol Med; 2011 Apr; 13():e14. PubMed ID: 21545756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of a T118M PMP22 missense mutation and chromosome 17 (17p11.2-p12) deletion.
    Jerath NU; Kamholz J; Grider T; Harper A; Swenson A; Shy ME
    Muscle Nerve; 2015 Nov; 52(5):905-8. PubMed ID: 26012543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.
    Rinaldi B; Villa R; Sironi A; Garavelli L; Finelli P; Bedeschi MF
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary neuropathy with liability to pressure palsies: study of six Spanish families].
    Pou Serradell A; Monells J; Téllez MJ; Fossas P; Löfgren A; Meuleman J; Timmerman V; De Jonghe P; Ceuterick C; Martin JJ
    Rev Neurol (Paris); 2002 May; 158(5 Pt 1):579-88. PubMed ID: 12072826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome.
    Bi W; Saifi GM; Shaw CJ; Walz K; Fonseca P; Wilson M; Potocki L; Lupski JR
    Hum Genet; 2004 Nov; 115(6):515-24. PubMed ID: 15565467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.